about
Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot studyNon-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scoresAbdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings.Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyFactors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.Effects of a dietary intervention with conjugated linoleic acid on immunological and metabolic parameters in children and adolescents with allergic asthma--a placebo-controlled pilot trialPathogenesis and management of nasal polyposis in cystic fibrosis.Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders.Adherence to therapies in cystic fibrosis: a targeted literature review.Smell in cystic fibrosis.Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.A patient nicknamed 'saline': atypical course with cystic fibrosis.[Early results of ultrasound based calculation of broadband ultrasound attenuation and speed of sound in children and adolescents suffering from asthma]Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation.Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients.Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients.Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial.Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonization.Coincident diagnosis of a pulmonary abscess and ascaris lumbricoides infection: a possible causal connection?[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa].Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?Associations between ghrelin levels in serum of preterm infants and enteral nutritional state during the first 6 months after birthPotential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosisCross-sectional study on bone density-related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severityAcute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisationCystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalationSinonasal persistence of Pseudomonas aeruginosa after lung transplantation[Terminal pulmonary insufficiency due to mild cystic fibrosis?]Substantially reduced calcaneal bone ultrasound parameters in severe untreated asthmaCystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A[Atypical cystic fibrosis. First diagnosed by chronic rhinosinusitis]Soluble inflammation markers in nasal lavage from CF patients and healthy controlsA rare differential diagnosis of acute chest pain after long-distance airplane flight[Pregnancy and cystic fibrosis - an overview]
P50
Q30442057-95FAA634-7649-4E4A-AF93-6C72D0AC2DBBQ30465393-AD2600F3-4296-4D52-B92F-7C0B089807BAQ33470424-4BD31DF0-E247-47C0-9147-05685CCA043CQ33624180-46F5749D-7393-48FE-BAAE-979873CB45C9Q34339563-512EB54D-D345-40D7-A40E-3F74BCA0DDA4Q35043722-3E98ED40-A506-4241-8642-CA8D33967269Q35817400-91453126-B253-4613-88FB-614EEF363830Q36197194-2C687F53-561D-4A50-A78C-DF129DEF1AE9Q36538687-8A9224A3-62C5-4F1E-9FD2-60EF4D7FAA1AQ37986573-ED5D9D39-EB72-4F5D-AE51-0ED2E13F550CQ38340865-5F3F817C-F9CE-42B3-BA92-65A10B37C3BFQ38960863-C65E0B0D-E771-43AE-B1C8-71391EC68AF6Q39096768-1366166C-50B1-43A8-8180-BFB5D05F87DEQ43432871-E50064B3-681A-4D6D-B234-E0200869FD93Q43549706-22B84BA7-82E9-4DCE-BB86-05C717D95DF2Q44266785-DAFFB965-A4BA-4E2E-BAA7-B9DC28E96A43Q44360590-6EDAC6F5-E7D4-45E7-8EC8-1453955A23B4Q44422095-FCD56357-BEB4-4A52-A511-ADCDD6655AD2Q47132564-F911DBF7-978C-4718-BE6E-75617C27FCC0Q47614002-8F5CD0BD-398B-416E-A94F-4A9806AFC872Q47731383-172A4307-948F-4AB6-BCF3-2D5515C817C5Q51692812-37469D39-57D9-4D82-961D-ECDECC19D8DBQ52602430-5A35FD7E-B6AC-4271-BCFB-76BB4C738EC1Q53150848-BE0A2EEB-5EE7-468C-A900-44D1DB9ACE46Q54212464-68FC5B70-5AAA-4FCE-9374-69F62C4CBDE1Q54395959-455E4C15-D8F8-44CD-A037-5A67F53BB48AQ62573969-7E22EFE7-6AA5-4E57-B00C-246E7BF96C20Q79281997-3380395A-03C3-4287-B335-E44063B49196Q79864660-5AF750B6-0785-42FB-BE28-5DA8C0BEAA28Q81898664-2E7AD135-64B5-484B-B7B3-52361D3C67BAQ82105182-96B7B471-4B0E-4C15-B3B2-1D5DB93913DBQ82299434-F761CA59-EA1F-4BB8-AAE7-099F53EEFCF9Q82766451-265F3EC6-7580-4840-91E4-9E3592901FD4Q83299235-F305CB53-620C-4313-9693-8CD53F5C46F4Q83398236-ED0C6434-A96F-4CF4-B1CA-62B7A71BC59CQ83955384-46D8862E-4D23-4123-BD0B-92191303D63EQ84243413-9CB35738-AD9D-4B6F-AB4F-236070E89B08Q84991928-392453C4-3EED-42D7-8467-5157DBA024B5Q85071532-85B535B8-5893-4878-A000-6218A33CD26DQ85287603-881E4874-BFA5-484B-BA13-4A16A8DF7D41
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jochen G Mainz
@ast
Jochen G Mainz
@en
Jochen G Mainz
@es
Jochen G Mainz
@nl
type
label
Jochen G Mainz
@ast
Jochen G Mainz
@en
Jochen G Mainz
@es
Jochen G Mainz
@nl
prefLabel
Jochen G Mainz
@ast
Jochen G Mainz
@en
Jochen G Mainz
@es
Jochen G Mainz
@nl
P106
P1153
16234411200
P31
P496
0000-0003-3780-7759